Human Glioma-Induced Immunosuppression Involves Soluble Factor(s) That Alters Monocyte Cytokine Profile and Surface Markers

作者: Thomas L. Roszman , Lorri A. Morford , John E. Coligan , Gene M. Shearer , Andrew G. Brooks

DOI:

关键词:

摘要: Patients with gliomas exhibit deficient in vitro and vivo T cell immune activity, human glioblastoma culture supernatants (GCS) inhibit lymphocyte responses. Because APC are essential for initiating regulating responses, we investigated whether GCS would affect cytokines produced by monocytes cells from healthy donors of PBMC. Incubation PBMC decreased production IL-12, IFN-γ, TNF-α, increased IL-6 IL-10. The GCS-induced changes IL-12 IL-10 occurred monocytes, involved p40 mRNA expression. also resulted reduced expression MHC class II CD80/86 costimulatory molecules on monocytes. immunosuppressive effects were not the result or TGF-β1 that was detected GCS. However, it due to a factor(s) is resistant pH extremes, differentially susceptible temperature, trypsin, has minimum molecular mass 40 kDa. Our findings show glioblastoma-generated factors known suppress responses alter cytokine profiles monocytic that, turn, function. This model indicates can serve as an intermediate between tumor-generated immune-suppressive suppressed gliomas.

参考文章(57)
Elliott L, Brooks W, Roszman T, Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas. Journal of the National Cancer Institute. ,vol. 78, pp. 919- 922 ,(1987)
Mark B. Orringer, Steven L. Kunkel, Robert M. Strieter, Richard I. Whyte, Marie D. Burdick, Carol A. Wilke, Daniel R. Smith, Production of interleukin-10 by human bronchogenic carcinoma. American Journal of Pathology. ,vol. 145, pp. 18- 25 ,(1994)
T L Roszman, L A Morford, L H Elliott, S L Carlson, W H Brooks, T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. Journal of Immunology. ,vol. 159, pp. 4415- 4425 ,(1997)
Vincenzo Bronte, David M. Segal, Robert A. Kirken, Giuseppe Sconocchia, Luis Dasilva, Federica Pericle, Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. Journal of Immunology. ,vol. 159, pp. 2580- 2585 ,(1997)
P. S. Linsley, R. N. Germain, L. Ding, E. M. Shevach, Li-Yun Huang, IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. Journal of Immunology. ,vol. 151, pp. 1224- 1234 ,(1993)
K Strommer, C Siepl, I Heid, A Fontana, S Bodmer, N de Tribolet, K Frei, Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. Journal of Immunology. ,vol. 143, pp. 3222- 3229 ,(1989)
A L Landay, H A Kessler, G M Shearer, M Clerici, R N Boswell, R A Zajac, S C Muluk, Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. Journal of Immunology. ,vol. 146, pp. 2207- 2213 ,(1991)
C.M.U. Hilkens, M.L. Kapsenberg, A. Snijders, F.G.M. Snijdewint, P. Kalinski, IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. Journal of Immunology. ,vol. 159, pp. 28- 35 ,(1997)
T L Roszman, L H Elliott, W H Brooks, Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors. Journal of Immunology. ,vol. 132, pp. 1208- 1215 ,(1984)
Ronald Bukowski, Patricia Rayman, Martha K Cathcart, James Finke, John O'Shea, Jerome Ritz, Mark Edinger, Raymond Tubbs, Andrew Novick, Qiu Wang, Vladimir Kolenko, M. C. Riedy, Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. Journal of Immunology. ,vol. 159, pp. 3057- 3067 ,(1997)